Hyaluronidase

1 current record 5 historicalEnzyme

Who holds supplier records for Hyaluronidase? 1 organisation holds a current record for Hyaluronidase: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 1 of them holds a valid EU Certificate of Suitability. Recorded organisation countries for current records: Italy (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Hyaluronidase: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/hyaluronidase

Reading the evidence

  • One current record

    One organisation holds a current DMF or CEP. A record shows a regulatory filing, not current commercial availability or a qualified source for your product.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (1)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Hyaluronidase. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Hyaluronidase sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (1)

Certificates of Suitability on the EDQM register for Hyaluronidase, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
BIOINDUSTRIA LABORATORIO ITALIANO MEDICINALI S.P.A. Novi LigureIT
CEP 2001-068 - Rev 01
Hyaluronidase
Aug 2025Inspected Apr 2025
Italy

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (5)

Organisations whose Type II DMFs for Hyaluronidase are no longer active. These show a past filing, not current supply.

Show all 5 historical records
  • SIGMA ALDRICH MANUFACTURING LLC
    Inactive DMF 26086 · filed May 2012
  • SERAVAC BIOTECH PTY LTD
    Inactive DMF 16622 · filed May 2003
  • United States · Inactive DMF 16273 · filed Nov 2002
  • DIOSYNTH BV
    Inactive DMF 4489 · filed Feb 1982
  • WORTHINGTON BIOCHEM CORP
    Inactive DMF 90 · filed Mar 1954

Overview

Hyaluronidase is a enzyme active pharmaceutical ingredient (ChEMBL CHEMBL1201636).

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Hyaluronidase?

1 organisation holds an active US FDA Type II Drug Master File or a CEP for Hyaluronidase: BIOINDUSTRIA LABORATORIO ITALIANO MEDICINALI SPA (Italy). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

What do the historical Hyaluronidase records mean?

5 organisations have only inactive Type II DMFs for Hyaluronidase. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Hyaluronidase have a European Certificate of Suitability?

Yes. 1 organisation holds a valid CEP for Hyaluronidase on the EDQM register, including BIOINDUSTRIA LABORATORIO ITALIANO MEDICINALI S.P.A. Novi Ligure (IT). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Hyaluronidase supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Hyaluronidase?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.